This dual mechanism enhances insulin secretion, suppresses glucagon release, slows gastric emptying, and reduces appetitecollectively promoting weight loss
Medical weight loss is available at Mullally Sports and Family Medicine
While highly effective for glycemic control and weight loss, clinical trials and FDA labeling indicate an association between semaglutide and acute gallbladder disease, including gallstones (cholelithiasis) and gallbladder inflammation (cholecystitis)
VEGFR2-mediated angiogenesis promotes the formation of new blood vessels, improving blood supply to tissues throughout the body
Clinically, prolonged use of statins reduces PD risk (Wahner et al., 2008)
doi: 10.3389/fnins.2019.00721 82